¡Ø Ãß¼® ¿¬ÈÞ ÈÞ¹«¾È³» : 2024³â 9¿ù 16ÀÏ(¿ù) ~ 2024³â 9¿ù 18ÀÏ(¼ö)

½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1505169

¼¼°èÀÇ ½ÉÇ÷°ü¿ë µðÁöÅÐ Çコ ½ÃÀå(2024-2031³â)

Global Digital Health For Cardiovascular Market 2024-2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Orion Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 145 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ½ÉÇ÷°ü¿ë µðÁöÅÐ Çコ ½ÃÀå ±Ô¸ð´Â 2024-2031³âÀÇ ¿¹Ãø ±â°£ µ¿¾È ¿¬Æò±Õ 22.4%ÀÇ ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½ÉÇ÷°ü¿ë µðÁöÅÐ °Ç°­Àº ½ÉÀå ¹× Ç÷°ü ÁúȯÀÇ ¿¹¹æ, Áø´Ü ¹× °ü¸®¸¦ °³¼±Çϱâ À§ÇØ ±â¼úÀ» È°¿ëÇÏ´Â ºÐ¾ßÀÔ´Ï´Ù. µµ±¸¿Í ¼­ºñ½º¿¡´Â ¿þ¾î·¯ºí ±â±â, ¸ð¹ÙÀÏ °Ç°­ ¾Û, ¿ø°Ý ÀÇ·á, ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ µîÀÌ Æ÷ÇԵ˴ϴÙ. ¿þ¾î·¯ºí ±â±â´Â ½É¹Ú¼ö, Ç÷¾Ð, È°µ¿·®À» ¸ð´ÏÅ͸µÇÏ°í, ¸ð¹ÙÀÏ °Ç°­ ¾ÛÀº Áõ»ó, Åõ¾à, °æ°ú¸¦ ÃßÀûÇÕ´Ï´Ù. ¿ø°Ý ÀÇ·á´Â ¿ø°ÝÁö¿¡¼­ ÀÇ»çÀÇ Áø·á¸¦ ¹ÞÀ» ¼ö ÀÖ°í, ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀº Àǻ簡 ¿ø°ÝÁö¿¡¼­ °Ç°­ µ¥ÀÌÅ͸¦ ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ÀÌ ±â¼úÀº »îÀÇ ÁúÀ» Çâ»ó½ÃÅ°°í ÀÇ·áºñ¸¦ Àý°¨ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡

Äڷγª19·Î ÀÎÇØ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ(RPM) ±â¼úÀÇ Ã¤ÅÃÀÌ °¡¼ÓÈ­µÇ°í ÀÖÀ¸¸ç, RPMÀ» ÅëÇØ ÀÇ·áÁøÀº üÁß, Ç÷¾Ð, Ç÷´ç µî ȯÀÚÀÇ °Ç°­ µ¥ÀÌÅ͸¦ ¿ø°ÝÀ¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ ÀáÀçÀûÀÎ ¹®Á¦¸¦ Á¶±â¿¡ ¹ß°ßÇÏ°í ÇØ°áÇÏ¿© ȯÀÚ °á°ú¸¦ °³¼±ÇÏ°í ÀÇ·á ºñ¿ëÀ» Àý°¨ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­

  • ÄÄÆ÷³ÍÆ®¿¡ µû¶ó ½ÃÀåÀº Çϵå¿þ¾î, ¼ÒÇÁÆ®¿þ¾î, ¼­ºñ½º·Î ¼¼ºÐÈ­µË´Ï´Ù.
  • ÃÖÁ¾ »ç¿ëÀÚ¿¡ µû¶ó ½ÃÀåÀº ȯÀÚ, °ø±ÞÀÚ, ÁöºÒÀÚ, ±âŸ·Î ¼¼ºÐÈ­µË´Ï´Ù.

Áö¿ªº° Àü¸Á

¼¼°è ½ÉÇ÷°ü¿ë µðÁöÅÐ Çコ ½ÃÀåÀº ºÏ¹Ì(¹Ì±¹, ij³ª´Ù), À¯·´(¿µ±¹, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, µ¶ÀÏ, ÇÁ¶û½º, ±âŸ À¯·´), ¾Æ½Ã¾ÆÅÂÆò¾ç(Àεµ, Áß±¹, ÀϺ», Çѱ¹, ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç), ±âŸ Áö¿ª(Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«, Áß³²¹Ì) µî Áö¿ªº°·Î ¼¼ºÐÈ­µÇ¾î ÀÖ½À´Ï´Ù. ¼¼ºÐÈ­µË´Ï´Ù.

ºÏ¹Ì°¡ ÁÖ¿ä ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÕ´Ï´Ù.

ºÏ¹Ì´Â ºü¸¥ ±â¼ú µµÀÔ, ¼±ÁøÈ­µÈ ÀÇ·á ½Ã½ºÅÛ, ¾çÈ£ÇÑ ±ÔÁ¦ ȯ°æ, ½ÉÇ÷°ü Áúȯ¿¡ ´ëÇÑ ³ôÀº ºÎ´ã, ºñ¿ë Àý°¨¿¡ ´ëÇÑ °ü½É µîÀ¸·Î ÀÎÇØ Å« Á¡À¯À²À» Â÷ÁöÇÏ°í ÀÖ½À´Ï´Ù. ¼±ÁøÈ­µÈ ÀÇ·á ½Ã½ºÅÛ, ÀÇ·á ±â°ü°ú À¯´ÉÇÑ Àü¹®°¡µéÀÇ ÁýÀû, °£¼ÒÈ­µÈ ±ÔÁ¦ ÇÁ·Î¼¼½º·Î ÀÎÇØ µðÁöÅÐ Çコ ¼Ö·ç¼Ç µµÀÔ¿¡ À¯¸®ÇÑ È¯°æÀÌ Á¶¼ºµÇ¾î ÀÖ½À´Ï´Ù.

¼¼°è ½ÉÇ÷°ü¿ë µðÁöÅÐ Çコ ½ÃÀå¿¡ ÁøÃâÇÑ ÁÖ¿ä ±â¾÷À¸·Î´Â Siemens Healthineers AG, Oracle(Cerner Corporation), Apple Inc. ½ÃÀå °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇØ ½ÃÀå ±â¾÷µéÀº Á¦ÈÞ, ÇÕº´, Àμö µîÀÇ Àü·«À» Àû¿ëÇÏ¿© »ç¾÷ È®Àå ¹× Á¦Ç° °³¹ß¿¡ Á¡Á¡ ´õ ¸¹Àº ³ë·ÂÀ» ±â¿ïÀÌ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 3¿ù »ï¼ºÀÇ ÀÚȸ»ç À£¸®½º(Wellysis)´Â ¹Ì±¹¿¡¼­ ¿ø°Ý ½ÉÀå ¸ð´ÏÅ͸µ ¼­ºñ½º¸¦ Ãâ½ÃÇϱâ À§ÇØ ¾Æ¸£ÅÚ¶ó ¼Ö·ç¼Ç(Artella Solutions, ARTELLA)°ú Á¦ÈÞ¸¦ ¸Î¾ú½À´Ï´Ù. ÀÌ Á¦ÈÞ´Â 10 °³ ÁÖ¿¡ °ÉÃÄ ARTELLAÀÇ FDA ÀÎÁõÀ» ¹ÞÀº S-Patch ½ÉÀüµµ ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀ» Á¦°øÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÏ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå º¸°í¼­ °³¿ä

  • »ê¾÷ ÇöȲ ºÐ¼®°ú ¼ºÀå °¡´É¼º Àü¸Á
  • Á¶»ç ¹æ¹ý°ú Åø
  • ½ÃÀå ³»¿ª
    • ºÎ¹®º°
    • Áö¿ªº°

Á¦2Àå ½ÃÀå °³¿ä¿Í ÀλçÀÌÆ®

  • Á¶»ç ¹üÀ§
  • ¾Ö³Î¸®½ºÆ® ÀλçÀÌÆ®¿Í ÇöÀç ½ÃÀå µ¿Çâ
    • ÁÖ¿ä »ê¾÷ µ¿Çâ
    • ½ÃÀå Ãßõ »çÇ×
    • °á·Ð

Á¦3Àå °æÀï ±¸µµ

  • ÁÖ¿ä ±â¾÷ ºÐ¼®
  • Apple Inc.
    • °³¿ä
    • À繫 ºÐ¼®
    • SWOT ºÐ¼®
    • ÃÖ±Ù µ¿Çâ
  • Oracle Corp.(Cerner)
  • Siemens Healthineers
  • ÁÖ¿ä Àü·« ºÐ¼®

Á¦4Àå ½ÃÀå ¼¼ºÐÈ­

  • ¼¼°èÀÇ ½ÉÇ÷°ü¿ë µðÁöÅÐ Çコ ½ÃÀå : ÄÄÆ÷³ÍÆ®º°
    • ¼ÒÇÁÆ®¿þ¾î
    • Çϵå¿þ¾î
    • ¼­ºñ½º
  • ¼¼°èÀÇ ½ÉÇ÷°ü¿ë µðÁöÅÐ Çコ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°
    • ȯÀÚ
    • Á¦°øÀÚ
    • ÁöºÒÀÚ
    • ±âŸ

Á¦5Àå Áö¿ª ºÐ¼®

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ÇÁ¶û½º
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ±âŸ Áö¿ª
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦6Àå ±â¾÷ °³¿ä

  • AlivCor, Inc.
  • Bardy Diagnostics, Inc.
  • CardiAI
  • Cleerly, Inc.
  • DOVEN
  • Epic Systems Corp.
  • HEALTH INFORMATION MANAGEMENT SYSTEMS
  • HeartFlow, Inc.
  • NXGN Management, LLC
  • RSIP Vision
  • Samsung
  • Verily Life Sciences LLC
  • Vista AI
  • Viz AI
LSH 24.07.09

Digital Health For Cardiovascular Market Size, Share & Trends Analysis Report by Component (Hardware, Software, and Services), by End-User (Patients, Payers, Providers and Other) Forecast Period (2024-2031)

Digital health for cardiovascular market is anticipated to grow at a CAGR of 22.4% during the forecast period (2024-2031). Digital health for cardiovascular disorders is a field that uses technology to improve the prevention, diagnosis, and management of heart and blood vessel diseases. Tools and services include wearable devices, mobile health apps, telemedicine, and remote patient monitoring. Wearable devices monitor heart rate, blood pressure, and activity levels, while mobile health apps track symptoms, medications, and progress. Telemedicine allows remote doctor visits, while remote patient monitoring allows doctors to monitor health data remotely. This technology can improve quality of life and reduce healthcare costs.

Market Dynamics

Growing Demand for Remote Patient Monitoring

The COVID-19 pandemic has accelerated the adoption of remote patient monitoring (RPM) technologies. RPM allows healthcare providers to monitor patients' health data remotely, such as weight, blood pressure, and blood sugar levels. This can help to identify and address potential problems early on, improving patient outcomes and reducing healthcare costs. For instance, in March 2024, Wellysis, a subsidiary of Samsung, collaborated with Artella Solutions (ARTELLA) to introduce a remote cardiac monitoring service.

Market Segmentation

  • Based on components, the market is sub-segmented into hardware, software, and services
  • Based on end-user, the market is augmented into patients, providers, payers, others

Regional Outlook

The global digital health for cardiovascular market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

North America Holds Major Market Share

North America holds a significant share driven by the rapid technology adoption, advanced healthcare systems, favorable regulatory landscape, high burden of cardiovascular disease, and focus on cost reduction. The country's advanced healthcare systems, a high concentration of medical institutions and qualified professionals, and streamlined regulatory processes make it a favorable environment for adopting digital health solutions.

The major companies serving the global digital health for the cardiovascular market include Siemens Healthineers AG, Oracle (Cerner Corporation), Apple Inc., Wellysis, and HeartFlow, Inc. among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers, and acquisitions to stay competitive in the market. For instance, in March 2024, Wellysis, a Samsung subsidiary, teamed up with Artella Solutions (ARTELLA) to unveil its remote cardiac monitoring service in the US. This partnership aims to offer the FDA-cleared S-Patch electrocardiogram monitoring solution from ARTELLA across ten states.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Industry Trends
    • 2.2.2. Market Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Apple Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Oracle Corp. (Cerner)
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Siemens Healthineers
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Digital Health For Cardiovascular Market by Component
    • 4.1.1. Software
    • 4.1.2. Hardware
    • 4.1.3. Services
  • 4.2. Global Digital Health for Cardiovascular Market by End-User
    • 4.2.1. Patients
    • 4.2.2. Providers
    • 4.2.3. Payers
    • 4.2.4. Others

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World
    • 5.4.1. Latin America
    • 5.4.2. Middle East & Africa

6. Company Profiles

  • 6.1. AlivCor, Inc.
  • 6.2. Bardy Diagnostics, Inc.
  • 6.3. CardiAI
  • 6.4. Cleerly, Inc.
  • 6.5. DOVEN
  • 6.6. Epic Systems Corp.
  • 6.7. HEALTH INFORMATION MANAGEMENT SYSTEMS (HIMS
  • 6.8. HeartFlow, Inc.
  • 6.9. NXGN Management, LLC
  • 6.10. RSIP Vision
  • 6.11. Samsung
  • 6.12. Verily Life Sciences LLC
  • 6.13. Vista AI
  • 6.14. Viz AI
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦